MYNOVOCURE
LIVE

Serial Number

97683297

Owner

NOVOCURE GMBH

Attorney

Hara K. Jacobs

First Use Date

Nov 21, 2031

Filing Date

Nov 18, 2022

Add to watchlist:

No watchlists yet
View on USPTO

MYNOVOCURE Trademark

Serial Number: 97683297 • Registration: 7415304

MYNOVOCURE is a trademark filed by NOVOCURE GMBH on November 18, 2022. The trademark is classified under Class 36 (Insurance & Financial), Class 41 (Education & Entertainment), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

NOVOCURE GMBH (39 trademarks)

ROOT D4 6039 , CH

Entity Type: 03

Trademark Details

Filing Date

November 18, 2022

Registration Date

June 11, 2024

First Use Anywhere

November 21, 2031

First Use in Commerce

November 21, 2023

Published for Opposition

July 25, 2023

Goods & Services

Medical educational services, namely, providing individualized and group instruction in the nature of training, classes, seminars and conferences for patients requiring treatment of solid tumor cancers and caregivers of patients requiring treatment of solid tumor cancers in the field of therapies and patient support for cancer treatment; educational services, providing of training and education, namely, providing information to caregivers in the areas of patient support services and information about therapies for cancer treatment, all of the aforesaid provided via telephone, e-learning and personal training sessions, and non-downloadable webinars and printed material distributed in connection therewith

Providing information about the financial administration of patient reimbursement programs designed to assist patients requiring treatment of solid tumor cancers regarding medical treatment payment plan options; providing patient support services, namely, providing insurance information to help patients requiring treatment of solid tumor cancers to understand their insurance and plan benefits and providing insurance reimbursement assistance to eligible patients

Providing information about the business administration of patient reimbursement programs designed to assist patients requiring treatment of solid tumor cancers regarding medical treatment payment plan options; providing business administration assistance to patients requiring treatment of solid tumor cancers regarding treatment payment plan options, namely, administration of patient reimbursement programs for patients requiring treatment of solid tumor cancers

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jun 11, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Jun 11, 2024 R.PR
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
May 8, 2024 ASCK
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
May 7, 2024 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
May 7, 2024 CNPR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 6, 2024 GNRN
NON-FINAL ACTION E-MAILED
May 6, 2024 GNRT
SU - NON-FINAL ACTION - WRITTEN
May 6, 2024 CNRT
STATEMENT OF USE PROCESSING COMPLETE
Mar 19, 2024 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Mar 19, 2024 AITU
USE AMENDMENT FILED
Feb 26, 2024 IUAF
TEAS STATEMENT OF USE RECEIVED
Feb 26, 2024 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 19, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 25, 2023 NPUB
PUBLISHED FOR OPPOSITION
Jul 25, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 5, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 20, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 16, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 15, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 15, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 13, 2023 GNRN
NON-FINAL ACTION E-MAILED
Jun 13, 2023 GNRT
NON-FINAL ACTION WRITTEN
Jun 13, 2023 CNRT
ASSIGNED TO EXAMINER
May 30, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 9, 2022 NWOS
NEW APPLICATION ENTERED
Nov 22, 2022 NWAP